View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
March 21, 2022

Medical Devices industry cross border deals total $2.3bn globally in February 2022

By Nikitha Ladda

Total medical devices industry cross border deals worth $2.3bn were announced globally for February 2022, with the $556.1m private equity deal for 60.8% stake with Classys being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 21.5% over the previous month of $2.89bn and a drop of 67.1% when compared with the last 12-month average of $6.9bn.

In terms of number of cross border deals, the sector saw a rise of 13.79% with 66 deals in February 2022 when compared to the last 12-month average of 58 deals.

In value terms, North America led the activity with cross border deals worth $1.06bn in February 2022.

medical devices industry cross border deals in February 2022: Top deals

The top five cross border deals accounted for 63.05% of the overall value during February 2022.

The combined value of the top five cross border deals stood at $1.43bn, against the overall value of $2.3bn recorded for the month.

The top five medical devices industry cross border deals of February 2022 tracked by GlobalData were:

1) Bain Capital Private Equity $556.1m private equity deal for 60.8% stake in Classys

2) The $325m venture financing of Somatus by Anthem,Blue Venture Fund,Deerfield ManagementLP,Fidelity Management & Research,Flare Capital Partners,General Insuranceof India,Inova Health System,Longitude Capital Management Co,Optum Ventures,RA Capital Management and Wellington ManagementLLP

3) Dreamtech $227.57m acquisition deal for 9.07% stake with Cardiac Insight

4) The $210m private equity deal with Micro Life Sciences by South Elm Investments B V

5) Alumni Ventures Group,aMoon Funds,Cowen Healthcare Investments,Echo Health Ventures,Hitachi Ventures,Khosla Ventures,Laurion Capital Management,Monashee Investment Management,Neuberger Berman Group,Northpond Ventures and Optum Ventures $110m venture financing deal with Scipher Medicine

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network